Clinical Trials Directory

Trials / Completed

CompletedNCT00780845

AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)

AKIN (Acute Kidney Injury Network): Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
817 (actual)
Sponsor
Hospital de Base · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is evaluate clinical outcomes and 30-day mortality after on-pump CABG.

Detailed description

Eight hundred and seventeen patients was enrolled in this series and divided into to groups: Group AKI (-) - patients without acute kidney injury after on-pump CABG. Group AKI (+) - patients with acute kidney injury after on-pump CABG. AKI was defined as an absolute increase in serum creatinine (SCr) of more than or equal to 0.3 mg/dl (≥ 26.4 μmol/l) or a percentage increase in SCr of more than or equal to 50% (1.5-fold from baseline). The change in SCr concentration was defined as the difference between immediate postoperative concentration and the highest concentration during the stay in ICU. Clinical Outcomes and 30-day mortality was evaluate in this patients.

Conditions

Timeline

Start date
2003-01-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2008-10-28
Last updated
2008-11-04

Source: ClinicalTrials.gov record NCT00780845. Inclusion in this directory is not an endorsement.